MultiPark: Multidisciplinary research focused on Parkinson´s disease

Organisation: strategiskt forskningsområde

Fler filtreringsmöjligheter
  1. Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

    Catalán, M. J., Antonini, A., Calopa, M., Băjenaru, O., de Fábregues, O., Mínguez-Castellanos, A., Per Odin, García-Moreno, J. M., Pedersen, S. W., Pirtošek, Z. & Kulisevsky, J., 2017 sep 1, I : eNeurologicalSci. 8, s. 44-53 10 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  2. Cardiovascular Diseases and Hippocampal Infarcts

    Rauramaa, T., Pikkarainen, M., Elisabet Englund, Ince, P. G., Jellinger, K., Paetau, A., Parkkinen, L. & Alafuzoff, I., 2011, I : Hippocampus. 21, 3, s. 281-287

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Cardiovascular Risk Factors Among Older Adults With Long-Term Spinal Cord Injury

    Sophie Jörgensen, Mattias Hill & Jan Lexell, 2019, I : PM and R. 11, 1, s. 8-16 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Caspase signalling controls microglia activation and neurotoxicity.

    Burguillos Garcia, M., Tomas Deierborg, Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Elisabet Englund, Venero, J. L. & Joseph, B., 2011, I : Nature. 472, s. 319-U214

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Cause of death and significant disease found at autopsy

    Niklas Friberg, Ljungberg, O., Berglund, E., Berglund, D., Ljungberg, R., Alafuzoff, I. & Elisabet Englund, 2019 dec, I : Virchows Archiv. 475, 6, s. 781–788

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease.

    Westin, K., Buchhave, P., Nielsen, H., Lennart Minthon, Sabina Janciauskiene & Oskar Hansson, 2012, I : PLoS ONE. 7, 1, e30525.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. CD44 Deficiency Is Associated with Increased Susceptibility to Stress-Induced Anxiety-like Behavior in Mice

    Barzilay, R., F. Ventorp, Segal-Gavish, H., Aharony, I., Bieber, A., Dar, S., Vescan, M., Globus, R., Weizman, A., Naor, D., Lipton, J., S. Janelidze, L. Brundin & Offen, D., 2016 dec, I : Journal of Molecular Neuroscience : MN. 60, 4, s. 548-558

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Cell-based therapies for Parkinson disease-past insights and future potential.

    Barker, R., Drouin-Ouellet, J. & Malin Parmar, 2015, I : Nature Reviews Neurology. 11, 9, s. 492-503

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  9. Cell-based therapy for Parkinson's disease: A journey through decades toward the light side of the Force

    Malin Parmar, Torper, O. & Drouin-Ouellet, J., 2019, I : European Journal of Neuroscience. 49, 4, s. 463-471

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Cell Replacement Therapy for Parkinson's Disease: Potential for Circuitry Repair

    Cardoso, T., 2018, Lund: Lund University: Faculty of Medicine. 92 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  11. CELL REPLACEMENT THERAPY FOR PARKINSON’S DISEASE: The importance of neuronal subtype, cell source and connectivity for functional recovery

    Shane Grealish, 2012, Division of Neurobiology. 180 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  12. Cell separation based on acoustophoresis and applications in health care

    Andreas Lenshof, Petersson, F., Per Augustsson, Grenvall, C., Simon Ekström, Persson, J., Swärd, A-M., Åberg, L., Mats Ohlin & Thomas Laurell, 2010.

    Forskningsoutput: KonferensbidragKonferensabstract

  13. Cells in Culture, Cells in Suspense: Practices of Cultural Production in Foetal Cell Research

    Andréa Wiszmeg, 2019 jan 18, Lund: Department of Arts and Cultural Sciences, Lund University. 210 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  14. Cell Therapeutics in Parkinson's Disease.

    Olle Lindvall & Anders Björklund, 2011, I : Neurotherapeutics. 8, s. 539-548

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Cell therapies for Parkinson's disease

    Malin Parmar, Kristina Hug, Bjartmarz, H., Johan Jakobsson, Göran Hermerén & Gesine Paul-Visse, 2014, I : Advances in Clinical Neuroscience and Rehabilitation. 14, 3, s. 26-28

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.

    Clausen, B. H., Lambertsen, K. L., Dagnæs-Hansen, F., Babcock, A. A., von Linstow, C. U., Meldgaard, M., Kristensen, B. W., Tomas Deierborg & Finsen, B., 2016, I : Acta Neuropathologica. 131, 5, s. 775-91

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. CELL THERAPY FOR PARKINSON'S DISEASE: PERSPECTIVES ON THE CLINICAL EXPERIENCE

    Deniz Kirik, 2010, I : Journal of Neurochemistry. 115, Suppl. 1, s. 2-2

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  18. Cell therapy for Parkinson's disease: what next?

    Anders Björklund & Kordower, J. H., 2013, I : Movement Disorders. 28, 1, s. 110-115

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Cell transplantation in Parkinson's disease: problems and perspectives.

    Jensen, L., Petit, G. & Brundin, P., 2010, I : Current Opinion in Neurology. 23, s. 426-432

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.

    Tim Fieblinger, Graves, S. M., Sebel, L. E., Cristina Alcacer, Plotkin, J. L., Gertler, T. S., Chan, C. S., Heiman, M., Greengard, P., Angela Cenci Nilsson & Surmeier, D. J., 2014, I : Nature Communications. 5, 5316.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Cerebral amyloid angiopathy: a long-term consequence of traumatic brain injury?

    Niklas Marklund, 2017 jan, I : Acta Neurochirurgica. 159, 1, s. 21-23 3 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Cerebral amyloid burden and Alzheimer's disease subtypes - does localization information matter?

    Zetterberg, H. & Niklas Mattsson, 2016, I : European Journal of Neurology. 23, 2, s. 233-234

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  23. Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.

    Danielle van Westen, Daniel Lindqvist, Blennow, K., Lennart Minthon, Katarina Nägga, Erik Stomrud, Zetterberg, H. & Oskar Hansson, 2016, I : Scientific Reports. 6, 20709.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Cerebrospinal fluid Alzheimer's disease biomarkers across the spectrum of lewy body diseases: Results from a large multicenter cohort

    Van Steenoven, I., Aarsland, D., Weintraub, D., Elisabet Londos, Blanc, F., Van Der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., Bonanni, L. & Lemstra, A. W., 2016 aug 23, I : Journal of Alzheimer's Disease. 54, 1, s. 287-295 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

    Sebastian Palmqvist, Philip S. Insel, Erik Stomrud, Shorena Janelidze, Zetterberg, H., Brix, B., Eichenlaub, U., Dage, J. L., Chai, X., Blennow, K., Niklas Mattsson & Oskar Hansson, 2019 dec 1, I : EMBO Molecular Medicine. 11, 12, e11170.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.

    Hans Brunnström, Rawshani, N., Zetterberg, H., Blennow, K., Lennart Minthon, Passant, U. & Elisabet Englund, 2010, I : Alzheimer's & Dementia. 6, 2, s. 104-109

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population

    Per Johansson, Mattsson, N., Oskar Hansson, Wallin, A., Johansson, J-O., Andreasson, U., Zetterberg, H., Blennow, K. & Svensson, J., 2011, I : Journal of Alzheimer's Disease. 24, 3, s. 537-546

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Cerebrospinal fluid concentrations of extracellular matrix proteins in Alzheimer's disease

    Minta, K., Portelius, E., Shorena Janelidze, Oskar Hansson, Zetterberg, H., Blennow, K. & Andreasson, U., 2019, I : Journal of Alzheimer's Disease. 69, 4, s. 1213-1220 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease

    Per Johansson, Almqvist, E. G., Johansson, J-O., Mattsson, N., Andreasson, U., Oskar Hansson, Wallin, A., Blennow, K., Zetterberg, H. & Svensson, J., 2013, I : PLoS ONE. 8, 11, e81989.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele

    Padayachee, E. R., Zetterberg, H., Portelius, E., Borén, J., Molinuevo, J. L., Andreasen, N., Cukalevski, R., S. Linse, Blennow, K. & Andreasson, U., 2016 nov 15, I : Brain Research. 1651, s. 11-16 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease

    Daborg, J., Andreasson, U., Pekna, M., Lautner, R., Hanse, E., Lennart Minthon, Blennow, K., Oskar Hansson & Zetterberg, H., 2012, I : Journal of Neural Transmission. 119, 7, s. 789-797

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia

    Olsson, B., Hertze, J., Mattias Ohlsson, Katarina Nägga, Hoglund, K., Basun, H., Annas, P., Lannfelt, L., Andreasen, N., Lennart Minthon, Zetterberg, H., Blennow, K. & Oskar Hansson, 2013, I : Journal of Alzheimer's Disease. 34, 3, s. 673-679

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

    Kvartsberg, H., Duits, F. H., Ingelsson, M., Andreasen, N., Öhrfelt, A., Andersson, K., Brinkmalm, G., Lannfelt, L., Lennart Minthon, Oskar Hansson, Andreasson, U., Teunissen, C. E., Scheltens, P., Van der Flier, W. M., Zetterberg, H., Portelius, E. & Blennow, K., 2015, I : Alzheimer's & Dementia. 11, 10, s. 1180-1190

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.

    Buchhave, P., Lennart Minthon, Zetterberg, H., Åsa Wallin, Blennow, K. & Oskar Hansson, 2012, I : Archives of General Psychiatry. 69, 1, s. 98-106

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Cerebrospinal Fluid Microglial Markers in Alzheimer's Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility

    Mattsson, N., Tabatabaei, S., Per Johansson, Oskar Hansson, Andreasson, U., Mansson, J-E., Johansson, J-O., Olsson, B., Wallin, A., Svensson, J., Blennow, K. & Zetterberg, H., 2011, I : NeuroMolecular Medicine. 13, 2, s. 151-159

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift